Liver Transplant a Safe Option After Recovery From COVID-19 Liver Transplant a Safe Option After Recovery From COVID-19
Once patients recover from COVID-19, liver transplantation is a safe option with no evidence of SARS-CoV-2 recurrence, according to a new study.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 30, 2021 Category: Gastroenterology Tags: Transplantation News Source Type: news

'Healthy' supplements are causing a rise in liver injuries - what to avoid
ACCORDING to new research, cases of severe liver injury linked to products claiming to promote muscle growth or weight loss are rising, with some severe cases leading to patients requiring liver transplants. Scientists are probing why some supplements may be doing more harm than good. (Source: Daily Express - Health)
Source: Daily Express - Health - July 27, 2021 Category: Consumer Health News Source Type: news

Outcomes for Living vs Deceased Donor Liver Transplantation Outcomes for Living vs Deceased Donor Liver Transplantation
The use of living donors in liver transplantation can help expand the organ donor pool, but how do the outcomes of this approach compare with that of deceased donor transplantation?American Journal of Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 26, 2021 Category: Consumer Health News Tags: Transplantation Journal Article Source Type: news

Dietary supplements causing severe liver injuries in Australians, with some requiring transplants, study shows
Researchers say cases linked to products claiming to promote muscle growth or weight loss are rising and more rigorous oversight is neededThe number of patients being admitted to hospital with severe liver injuries caused by herbal and dietary supplements claiming to promote muscle growth or weight loss is increasing, with some people harmed so severely they required a liver transplant.A study led by Dr Emily Nash from the Royal Prince Alfred hospital examined hospital records of 184 adults admitted to the AW Morrow Gastroenterology and Liver Centre with drug-induced liver injury between 2009 and 2020. She and her co-autho...
Source: Guardian Unlimited Science - July 25, 2021 Category: Science Authors: Melissa Davey Tags: Health Australia news Diets and dieting Medical research Food safety Source Type: news

Hepatitis B Virus Monitoring Needed After Liver Transplantation
FRIDAY, July 9, 2021 -- Health care providers should test liver recipients for hepatitis B virus (HBV) given the slight risk for unexpected donor-derived HBV infection, according to research published in the July 9 issue of the U.S. Centers for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 9, 2021 Category: Pharmaceuticals Source Type: news

The ethics of split liver transplantation: Analyzing case studies to make the right decision
(Carnegie Mellon University) In a new article, researchers address some of the ethical decisions that go into decisions to split a liver and provide a model to help hospitals make SLT decisions. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 9, 2021 Category: International Medicine & Public Health Source Type: news

Unexpected Hepatitis B Virus Infection After Liver Transplantation - United States, 2014-2019
This report describes donor-derived hepatitis B virus infections after liver transplantation. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 8, 2021 Category: American Health Tags: Hepatitis B MMWR Morbidity & Mortality Weekly Report Organ Translplants Source Type: news

What Problems are Ciliopathies Associated With?
Discussion Nephronophthisis (NPHP) one cause of end-stage renal disease (ESRD) usually occurring before age 30 years. NPHP is a non-motile ciliopathy affecting cellular sensing in the renal tubular epithelium. See To Learn More below. The incidence varies according to location with 1:1 million in the US but 1:50,000 in Finland. There are 3 subtypes: Infantile Occurs usually within 1 year of life Enlarged kidneys and severe hypertension In utero can have oligohydramnios problems such as pulmonary hypoplasia, facial dysmorphisms, limb contractures Extra-renal problems include congenital heart disease, liver fibrosis, recur...
Source: PediatricEducation.org - July 5, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Novel Liver Dialysis Device May Safely Curb ACLF Novel Liver Dialysis Device May Safely Curb ACLF
The investigational DIALIVE liver dialysis system removes and replaces albumin and filters endotoxins in patients with acute-on-chronic liver failure.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - July 2, 2021 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

Worse Survival With Recurrent AIH After Transplant Worse Survival With Recurrent AIH After Transplant
Autoimmune hepatitis that recurs following a liver transplant can impair both graft survival and overall survival.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 1, 2021 Category: Surgery Tags: Gastroenterology News Source Type: news

Resmetirom Shows Promise for Fatty Liver in Early Analysis Resmetirom Shows Promise for Fatty Liver in Early Analysis
Resmetirom, an experimental treatment for nonalcoholic steatohepatitis, improved biomarkers for the condition in the preliminary analysis of a phase 3 trial.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - July 1, 2021 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

For transplant patients, COVID-19 vaccination presents a different uncertainty
(University of California - San Diego) Researchers at UC San Diego Health have launched a pair of clinical trials to study the immune response of COVID-19 vaccinated transplant recipients of bone marrow and solid organs, such as the heart, lung, liver and kidney. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

The Pandemic Hurt Patients With Liver Disease in Many Ways The Pandemic Hurt Patients With Liver Disease in Many Ways
Deferred monitoring, delayed treatment, and increased alcoholism added to the burden of COVID-19 itself to make the pandemic especially hard on people with liver disease.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - June 30, 2021 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

Liver Cirrhosis Much More Deadly for Black Americans
FRIDAY, June 25, 2021 -- Black Americans with cirrhosis— late-stage liver disease— are much less likely to receive a liver transplant and more likely to die than white patients, new research reveals. For the study, researchers at... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 25, 2021 Category: General Medicine Source Type: news

Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with co...
Source: Johnson and Johnson - June 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Black patients with cirrhosis more likely to die, less likely to get liver transplant
(Northwestern University) Black patients with cirrhosis - late-stage liver disease - are about 25% more likely to die compared to non-Hispanic white patients and four times less likely to receive a liver transplant, reports a new study. Estimates of racial disparity in cirrhosis have been limited by a lack of large-scale longitudinal data. The paper is one of the first to link all seven large liver centers in Chicago with the death registry and transplant registry to examine racial disparities in cirrhosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 23, 2021 Category: International Medicine & Public Health Source Type: news

Liver Transplant Outcomes Improving for US Patients With HIV/HCV Liver Transplant Outcomes Improving for US Patients With HIV/HCV
Hepatitis C virus (HCV) infection no longer confers worse patient survival in the era of direct-acting antiviral therapy, but the population remains underserved.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - May 28, 2021 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

Updated Data Demonstrate Significant Improvement in Hematologic Complete Response with DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
RARITAN, N.J., May 26, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated results from the Phase 3 ANDROMEDA study, which evaluated DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for the treatment of patients with newly diagnosed light chain (AL) amyloidosis, a rare blood cell disorder associated with the deterioration of vital organs, most notably the heart, kidneys and liver.[1] Longer-term results from a median follow-up of 20.3 months showed rates of hematologic complete response (hemCR) remained significantly higher in patients treated with DARZALEX FASPRO®...
Source: Johnson and Johnson - May 26, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Ultrasound AI model can help evaluate chronic kidney disease
Artificial intelligence (AI)-based analysis of kidney ultrasound studies coul...Read more on AuntMinnie.comRelated Reading: Brain imaging with CT, MRI in kidney cancer patients finds metastases AI plus CT improves liver steatosis assessment CEUS helps predict chronic kidney disease progression Caution indicated with new GBCAs for kidney patients Prehydration not needed before contrast CT of kidneys (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 24, 2021 Category: Radiology Source Type: news

Late-Breaking Data at ACC.21 Show XARELTO ® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization
RARITAN, N.J., May 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today presented new data from the Phase 3 VOYAGER PAD study which showed XARELTO® (rivaroxaban) (2.5 mg twice daily) in combination with aspirin (100 mg once daily) consistently reduced severe vascular events in patients with peripheral artery disease (PAD) after lower-extremity revascularization (LER) compared to aspirin alone regardless of whether it was the first, second, third, or subsequent event. The primary results of VOYAGER PAD showed that XARELTO® plus aspirin reduced first events by 15 percent among patients...
Source: Johnson and Johnson - May 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Report of First US Living Donor Liver Transplant Chain Report of First US Living Donor Liver Transplant Chain
One transplant center reports their experience with a living donor liver transplant chain. Could this help expand the donor pool for liver transplantation?American Journal of Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 5, 2021 Category: Consumer Health News Tags: Transplantation Journal Article Source Type: news

Mayo Clinic Q & amp;A podcast: Reducing rejection by reversing order of heart-liver transplant
For heart-liver transplants, the liver and heart must come from the same donor, and some patients wait years to receive both organs. Also, antibodies from the donor can increase chances of the receiving patient rejecting the heart. But Dr. Sudhir Kushwaha, a Mayo Clinic cardiovascular transplant surgeon, says when a liver transplant is also involved, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 27, 2021 Category: Databases & Libraries Source Type: news

Plasmapheresis in lethal yellow phosphorus poisoning: a scope for recovery - Mathew J, Gnanaraj J, Basavarajegowda A, Venkateswaran R.
A 16-year-old girl presented with grade 3 hepatic encephalopathy (HE) following suicide attempt after consuming a lethal dose of yellow phosphorus containing rodenticide. Although she was a candidate for liver transplantation, it could not be done. In the ... (Source: SafetyLit)
Source: SafetyLit - April 26, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

COVID-19 News from Annals of Internal Medicine
(American College of Physicians) 1. Liver transplant recipient reinfected with SARS-CoV-2 infection 3 months after initial diagnosis ; 2. People of color have substantially higher risk for hospitalization, intensive-level care for COVID-19 than White persons (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 19, 2021 Category: Infectious Diseases Source Type: news

Scientists Report Creating the First Embryo With Human and Non-Human Primate Cells
In a ground-breaking experiment, researchers have successfully created the first human-monkey chimera. The work, published in the journal Cell, describes the the first embryo containing both human and monkey cells that was cultured for 20 days. Led by Juan Carlos Izpisua Belmonte, the study represents the culmination of decades of work in understanding early embryo development in non-human species, which Belmonte hopes will now apply to humans. But it is bound to raise serious ethical questions about the implications of combining human cells with those from a different species (even if it is a closely related one), and the...
Source: TIME: Health - April 15, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Source Type: news

Closer to human -- Mouse model more accurately reproduces fatty liver disease
(Baylor College of Medicine) Researchers have developed a novel mouse model that reproduces many key features of human non-alcoholic fatty liver disease (NAFLD), a little-understood condition that significantly increases the risk of inflammation, fibrosis and liver cancer and ultimately requires liver transplant. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 13, 2021 Category: Cancer & Oncology Source Type: news

Deep Learning model developed at UHN to maximize lifespan after liver transplant  
(University Health Network) Researchers from University Health Network have developed and validated an innovative deep learning model to predict a patient's long-term outcome after receiving a liver transplant. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 12, 2021 Category: International Medicine & Public Health Source Type: news

Liver Transplant Emerges for Hepatic Mets in Colorectal Cancer Liver Transplant Emerges for Hepatic Mets in Colorectal Cancer
A new indication for a scarce resource?Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 5, 2021 Category: Surgery Tags: Hematology-Oncology News Source Type: news

NIH scientists develop breath test for methylmalonic acidemia
Test for rare genomic condition measures disease severity and success of liver transplantation for patients. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - April 5, 2021 Category: American Health Source Type: news

NIH scientists develop breath test for methylmalonic acidemia
(NIH/National Human Genome Research Institute) Researchers at the National Institutes of Health have developed a breath test that measures how well patients with methylmalonic acidemia (MMA) respond to receiving liver or combined liver and kidney transplantation. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 5, 2021 Category: Biology Source Type: news

Sharing Mayo Clinic: Daughter quits smoking to donate liver to her mom
When she learned that a liver transplant could save her mom's life, April Wilson didn't hesitate to stop smoking and say yes to being a living donor. April Wilson smoked for 25 years and tried many times to quit, but nothing seemed to work. "I tried everything," April says. "I used every replacement therapy, Chantix, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 4, 2021 Category: Databases & Libraries Source Type: news

Reverse-order heart-liver transplant helps prevent rejection for certain patients
(Mayo Clinic) All too often, patients with high levels of antibodies face major challenges getting a transplant. These highly sensitized patients have a much higher risk of death while waiting for suitable organs they are less likely to reject. But there is new hope for highly sensitized patients in need of a combined heart and liver transplant, thanks to an innovative surgical approach at Mayo Clinic. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 1, 2021 Category: International Medicine & Public Health Source Type: news

Reverse-order heart-liver transplant helps prevent rejection for highly sensitized patients
ROCHESTER, Minn. -- All too often, patients with high levels of antibodies face major challenges getting a transplant. These highly sensitized patients have a much higher risk of death while waiting for suitable organs they are less likely to reject. But there is new hope for highly sensitized patients in need of a combined heart [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - April 1, 2021 Category: Hospital Management Source Type: news

Mayo Clinic Q & amp;A podcast: Liver failure and transplant in children
A liver transplant is a surgical procedure that removes a liver that no longer functions properly and replaces it with a healthy liver from a deceased donor or a portion of a healthy liver from a living donor. The process for liver transplant in children is similar to the process for adults. But because children with liver [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 26, 2021 Category: Databases & Libraries Source Type: news

Patient With Post-COVID-19 Cholangiopathy Undergoes Successful Liver Transplant Patient With Post-COVID-19 Cholangiopathy Undergoes Successful Liver Transplant
A 47-year-old man who recovered from acute respiratory distress syndrome related to COVID-19 and then went on to develop end-stage liver disease is doing well after liver transplantation, according to a new report.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - March 25, 2021 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

Organ Allocation Rule Change Has Liver Recovery Teams Traveling Twice as Far Organ Allocation Rule Change Has Liver Recovery Teams Traveling Twice as Far
A change in how organs are allocated for transplant has resulted in recovery teams traveling twice as far to collect livers, a US study suggests.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - March 20, 2021 Category: Transplant Surgery Tags: Transplantation News Source Type: news

Minorities Underrepresented on Liver Transplant Waiting Lists Minorities Underrepresented on Liver Transplant Waiting Lists
While racial disparities'greatly diminished'after placement on a waiting list, prewait-listing disparities may be more challenging to overcome, reported lead author Curtis Warren.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 9, 2021 Category: Gastroenterology Tags: General Surgery News Source Type: news

Over 100 liver transplantations done in 10 years: ILBS
Several pediatric liver transplants that took place at the ILBS were because of the help of the "government or crowd funding", according to a statement by the institute. (Source: The Economic Times)
Source: The Economic Times - March 9, 2021 Category: Consumer Health News Source Type: news

Sharing Mayo Clinic: Transplant patient says 'I'm in the safest place I can be'
George Caceres' smile is contagious. Just ask his Mayo Clinic care team, who came to know him well during his 165-day stay after a liver transplant. "He was so pleasant to visit," says Lyda Velez, his case manager. "Even on days when he didn't feel well and didn't take off his [sleep] mask, he would [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 28, 2021 Category: Databases & Libraries Source Type: news

Hypothermic Machine Perfusion Prevents Complications in Donated-After-Cardiac-Death Liver Allografts Hypothermic Machine Perfusion Prevents Complications in Donated-After-Cardiac-Death Liver Allografts
When preparing livers for transplant, hypothermic oxygenated machine perfusion slashes the odds of nonanastomotic biliary stricture by two thirds, according to a European study.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - February 26, 2021 Category: Transplant Surgery Tags: Transplantation News Source Type: news

Cholangiocyte organoids can repair bile ducts after transplantation in the human liver
Organoid technology holds great promise for regenerative medicine but has not yet been applied to humans. We address this challenge using cholangiocyte organoids in the context of cholangiopathies, which represent a key reason for liver transplantation. Using single-cell RNA sequencing, we show that primary human cholangiocytes display transcriptional diversity that is lost in organoid culture. However, cholangiocyte organoids remain plastic and resume their in vivo signatures when transplanted back in the biliary tree. We then utilize a model of cell engraftment in human livers undergoing ex vivo normothermic perfusion to...
Source: ScienceNOW - February 18, 2021 Category: Science Authors: Sampaziotis, F., Muraro, D., Tysoe, O. C., Sawiak, S., Beach, T. E., Godfrey, E. M., Upponi, S. S., Brevini, T., Wesley, B. T., Garcia-Bernardo, J., Mahbubani, K., Canu, G., Gieseck, R., Berntsen, N. L., Mulcahy, V. L., Crick, K., Fear, C., Robinson, S., Tags: Cell Biology, Medicine, Diseases reports Source Type: news

Should Someone With Asthma Get a COVID-19 Vaccine Before Someone With Cancer? The Next Big Challenge in the Vaccine Rollout
In an ideal world, there would be enough vaccines to inoculate everyone who wanted to get immunized against COVID-19. People would get their shots on a first come, first serve basis, we’d achieve herd immunity in a matter of months and COVID-19 would become a soon-distant memory. But with some 240 million people over age 16 who need a COVID-19 vaccine (and two doses at that), and just over 42 million administered by early February, supply is far below demand, and will likely remain that way for months to come, despite vaccine makers pushing production lines as hard as they can. As the U.S. works through the vaccine ...
Source: TIME: Health - February 10, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

New clinic to open at one of Greater Dayton's largest hospital campuses
A new clinic is slated to open in February at one of Greater Dayton's largest hospital campuses. UC Health on Monday announced plans to open a liver transplant evaluation clinic Feb. 19 at Physicians Office North — a freestanding facility at its West Chester Hospital campus in Butler County. The clinic at 7690 Discovery Drive aims to provide easier access for patients living in Dayton, Mi ddletown and Troy, the health system said. "Opening this clinic will enable more liver transplant patients… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 27, 2021 Category: Health Management Authors: Jacob Fisher Source Type: news

Non-Hispanic Blacks Underrepresented on Transplant Wait List
THURSDAY, Jan. 21, 2021 -- Non-Hispanic Black patients are disproportionately left off liver transplant wait lists, according to a study published online Jan. 11 in the Journal of the American College of Surgeons. Curtis Warren, M.P.H., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 21, 2021 Category: Pharmaceuticals Source Type: news

Patients Fend for Themselves to Access COVID Antibody Treatments Patients Fend for Themselves to Access COVID Antibody Treatments
Herritz found himself very much on his own. His primary care doctor wasn't sure he qualified for treatment. His transplant team in Wisconsin, where he'd had the liver surgery, wasn't calling back.Kaiser Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - January 20, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
January 15, 2021 (HORSHAM, Pa.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis.[1] DARZALEX FASPRO® is the first and only FDA-approved treatment for patients with this blood cell disorder that is associated with the production of an abnormal protein, which leads to th...
Source: Johnson and Johnson - January 16, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Black Patients Disproportionately Left Off Liver Transplant Waitlists Black Patients Disproportionately Left Off Liver Transplant Waitlists
Liver-transplant waitlists at many US centers under-represent Black patients compared with what would be expected based on their service area, new research suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 15, 2021 Category: Surgery Tags: Transplantation News Source Type: news

In lab study, nanoparticle shows promising results for treating severe allergies
For about 1 in 13 children in the U.S., usually harmless foodstuffs such as milk, eggs and peanuts can send the body ’s natural defenses into overdrive.Symptoms of food allergies can vary widely, but at worst, a systemwide allergic response can lead to anaphylaxis, a life-threatening condition characterized by a sudden drop in blood pressure and difficulty breathing.Although there are now some preventive measures for food-induced anaphylaxis, there are not yet any long-lasting solutions — treatments capable of locking the immune system into a state of tolerance, so that it doesn’t respond to allergens.Now...
Source: UCLA Newsroom: Health Sciences - January 14, 2021 Category: Universities & Medical Training Source Type: news